Association between polypharmacy and dementia – A systematic review and metaanalysis

References

• Alhawassi, T. M., Krass, I., Bajorek, B. V., & Pont, L. G. (2014). A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clinical Interventions in Aging, 9, 2079–2086. doi: 10.2147/CIA.S71178
   Web of Science ®Google Scholar
• Alhmoud, E., Khalifa, S., & Bahi, A. A. (2015). Prevalence and predictors of potentially inappropriate medications among home care elderly patients in Qatar. International Journal of Clinical Pharmacy, 37(5), 815–821. doi: 10.1007/s11096-015-0125-0
   Web of Science ®Google Scholar
• Alomar, M. J. (2014). Factors affecting the development of adverse drug reactions (Review article). Saudi Pharmaceutical Journal, 22(2), 83–94. doi: 10.1016/j.jsps.2013.02.003
   PubMed Web of Science ®Google Scholar
• Andersen, F., Viitanen, M., Halvorsen, D. S., Straume, B., & Engstad, T. A. (2011). Co-morbidity and drug treatment in Alzheimer's disease. A cross sectional study of participants in the Dementia Study in Northern Norway. BMC Geriatrics, 11(1), 58. doi: 10.1186/1471-2318-11-58
   PubMed Web of Science ®Google Scholar
• Arnljots, R., Thorn, J., Elm, M., Moore, M., & Sundvall, P. D. (2017). Vitamin D deficiency was common among nursing home residents and associated with dementia: A cross sectional study of 545 Swedish nursing home residents. BMC Geriatrics, 17(1), 229. doi: 10.1186/s12877-017-0622-1
   PubMedGoogle Scholar
• Borchelt, M. (1995). [Potential side-effects and interactions in multiple medication in elderly patients: Methodology and results of the Berlin Study of Aging]. Zeitschrift Fur Gerontologie Und Geriatrie, 28(6), 420–428.
   Google Scholar
• Bradley, M. C., Motterlini, N., Padmanabhan, S., Cahir, C., Williams, T., Fahey, T., & Hughes, C. M. (2014). Potentially inappropriate prescribing among older people in the United Kingdom. BMC Geriatrics, 14(1), 72. doi: 10.1186/1471-2318-14-72
   PubMedGoogle Scholar
• Brodaty, H., & Donkin, M. (2009). Family caregivers of people with dementia. Dialogues in Clinical Neuroscience, 11(2), 217–228.
   PubMedGoogle Scholar
• Brown, J. (2015). The use and misuse of short cognitive tests in the diagnosis of dementia. Journal of Neurology, Neurosurgery & Psychiatry, 86 (6), 680–685. doi: 10.1136/jnnp-2014-309086
   Web of Science ®Google Scholar
• Chen, J. H., Lin, K. P., & Chen, Y. C. (2009). Risk factors for dementia. Journal of the Formosan Medical Association, 108(10), 754–764. doi: 10.1016/s0929-6646(09)60402-2
   Web of Science ®Google Scholar
• Chertkow, H., Feldman, H. H., Jacova, C., & Massoud, F. (2013). Definitions of dementia and predementia states in Alzheimer's disease and vascular cognitive impairment: Consensus from the Canadian conference on diagnosis of dementia. Alzheimer's Research & Therapy, 5(Suppl 1), S2.doi: 10.1186/alzrt198
   PubMedGoogle Scholar
• Clague, F., Mercer, S. W., McLean, G., Reynish, E., & Guthrie, B. (2017). Comorbidity and polypharmacy in people with dementia: Insights from a large, population-based cross-sectional analysis of primary care data. Age and Ageing, 46(1), 33–39. doi: 10.1093/ageing/afw176
   PubMed Web of Science ®Google Scholar
• Cool, C., Cestac, P., Laborde, C., Lebaudy, C., Rouch, L., Lepage, B., … Lapeyre-Mestre, M. (2014). Potentially inappropriate drug prescribing and associated factors in nursing homes. Journal of the American Medical Directors Association, 15(11), 850.e851–859. doi: 10.1016/j.jamda.2014.08.003
   Web of Science ®Google Scholar
• del Ser, T., Barba, R., Morin, M. M., Domingo, J., Cemillan, C., Pondal, M., & Vivancos, J. (2005). Evolution of cognitive impairment after stroke and risk factors for delayed progression. Stroke; A Journal of Cerebral Circulation, 36(12), 2670–2675. doi: 10.1161/01.str.0000189626.71033.35
   Web of Science ®Google Scholar
• Emre, M. (2009). Classification and diagnosis of dementia: A mechanism- based approach. European Journal of Neurology, 16(2), 168–173. doi: 10.1111/j.1468-1331.2008.02379.x
   Web of Science ®Google Scholar
• Fratiglioni, L. (2011). MCI: Occurrence, risk factors, progression; evidence from the Kungsholmen project. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 7(4), S495. doi: 10.1016/j.jalz.2011.05.2384
   Google Scholar
• Fulton, M. M., & Allen, E. R. (2005). Polypharmacy in the elderly: A literature review. Journal of the American Academy of Nurse Practitioners, 17(4), 123–132. doi: 10.111/j.1041-2972.2005.0020.x
   Google Scholar
• Galvin, J. E., & Sadowsky, C. H. (2012). Practical guidelines for the recognition and diagnosis of dementia. Journal of the American Board of Family Medicine, 25(3), 367–382. doi: 10.3122/jabfm.2012.03.100181
   Web of Science ®Google Scholar
• Gnjidic, D., Hilmer, S. N., Blyth, F. M., Naganathan, V., Waite, L., Seibel, M. J., … Le Couteur, D. G. (2012). Polypharmacy cutoff and outcomes: Five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. Journal of Clinical Epidemiology, 65(9), 989–995. doi: 10.1016/j.jclinepi.2012.02.018
   Web of Science ®Google Scholar
• Gomm, W., von Holt, K., Thome, F., Broich, K., Maier, W., Fink, A., … Hae- nisch, B. (2016). Association of proton pump inhibitors with risk of dementia: A Pharmacoepidemiological claims data analysis. JAMA Neurology, 73(4), 410–416. doi: 10.1001/jamaneurol.2015.4791
   Web of Science ®Google Scholar
• Gomm, W., von Holt, K., Thome, F., Broich, K., Maier, W., Weckbecker, K., … Haenisch, B. (2016). Regular benzodiazepine and Z-Substance use and risk of dementia: An analysis of German claims data. Journal of Alz- heimers Disease, 54(2), 801–808. doi: 10.3233/jad-151006
   Web of Science ®Google Scholar
• Green, A. R., Segal, J., Tian, J., Oh, E., Roth, D. L., Hilson, L., … Boyd, C. M. (2017). Use of bladder Antimuscarinics in older adults with impaired cognition. Journal of the American Geriatrics Society, 65(2), 390–394. doi: 10.1111/jgs.14498
   PubMed Web of Science ®Google Scholar
• Gupta, M., Singh, R., Singh, K., & Lehl, S. S. (2013). Reversible dementia and gait disturbance as a result of polypharmacy. BMJ Case Reports, 2013, 1–2. doi: 10.1136/bcr-2013-008932
   Google Scholar
• Haenisch, B., von Holt, K., Wiese, B., Prokein, J., Lange, C., Ernst, A., … Scherer, M. (2015). Risk of dementia in elderly patients with the use of proton pump inhibitors. European Archives of Psychiatry and Clinical Neuroscience, 265(5), 419–428. doi: 10.1007/s00406-014-0554-0
   Web of Science ®Google Scholar
• Herzog, R., Alvarez-Pasquin, M. J., Diaz, C., Del Barrio, J. L., Estrada, J. M., & Gil, A. (2013). Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health [Electronic Resource], 13, 154. doi: 10.1186/1471-2458-13-154
   PubMed Web of Science ®Google Scholar
• Higgins, J. P., & Thompson, S. G. (2002). Quantifying heterogeneity in a meta-analysis. Statistics in Medicine, 21(11), 1539–1558. doi: 10.1002/sim.1186
   Web of Science ®Google Scholar
• Hudhra, K., Garcia-Caballos, M., Casado-Fernandez, E., Jucja, B., Shabani, D., & Bueno-Cavanillas, A. (2016). Polypharmacy and potentially inappropriate prescriptions identified by Beers and STOPP criteria in co-morbid older patients at hospital discharge. Journal of Evaluation in Clinical Practice, 22(2), 189–193. doi: 10.1111/jep.12452
   PubMed Web of Science ®Google Scholar
• Hulse, G. K., Lautenschlager, N. T., Tait, R. J., & Almeida, O. P. (2005). Dementia associated with alcohol and other drug use. International Psychogeriatrics, 17(Suppl 1), S109–S127.
   PubMedGoogle Scholar
• Jorm, A. F., Mather, K. A., Butterworth, P., Anstey, K. J., Christensen, H., & Easteal, S. (2007). APOE genotype and cognitive functioning in a large age-stratified population sample. Neuropsychology, 21(1), 1–8. doi: 10.1037/0894-4105.21.1.1
   PubMed Web of Science ®Google Scholar
• Kalisch Ellett, L. M., Pratt, N. L., Ramsay, E. N., Barratt, J. D., & Roughead, E. E. (2014). Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia. Journal of the American Geriatrics Society, 62(10), 1916–1922. doi: 10.1111/jgs.13054
   Web of Science ®Google Scholar
• Kose, E., Maruyama, R., Okazoe, S., & Hayashi, H. (2016). Impact of Polypharmacy on the rehabilitation outcome of Japanese stroke patients in the convalescent rehabilitation ward. Journal of Aging Research, 2016, 8. doi: 10.1155/2016/7957825
   Google Scholar
• Kouladjian, L., Gnjidic, D., Chen, T. F., Mangoni, A. A., & Hilmer, S. N. (2014). Drug burden index in older adults: Theoretical and practical issues. Clinical Interventions in Aging, 9, 1503–1515. doi: 10.2147/CIA.S66660
   PubMed Web of Science ®Google Scholar
• Lai, S. W., Lin, C. H., Liao, K. F., Su, L. T., Sung, F. C., & Lin, C. C. (2012). Association between polypharmacy and dementia in older people: A population-based case-control study in Taiwan. Geriatrics & Gerontology International, 12(3), 491–498. doi: 10.1111/j.1447-0594.2011.00800.x
   Web of Science ®Google Scholar
• Lau, D. T., Mercaldo, N. D., Harris, A. T., Trittschuh, E., Shega, J., & Wein- traub, S. (2010). Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia. Alzheimer Disease and Associated Disorders, 24(1), 56–63. doi: 10.1097/WAD.0b013e31819d6ec9
   PubMed Web of Science ®Google Scholar
• Lau, D. T., Mercaldo, N. D., Shega, J. W., Rademaker, A., & Weintraub, S. (2011). Functional decline associated with polypharmacy and potentially inappropriate medications in community-dwelling older adults with dementia. American Journal of Alzheimers Disease and Other Dementias, 26(8), 606–615. doi: 10.1177/1533317511432734
   Web of Science ®Google Scholar
• Leelakanok, N., Holcombe, A. L., Lund, B. C., Gu, X., & Schweizer, M. L. (2017). Association between polypharmacy and death: A systematic review and meta-analysis. Journal of the American Pharmaceutical Association, 57(6), 729–738.e710. doi: 10.1016/j.japh.2017.06.002
   Google Scholar
• Maher, R. L., Hanlon, J. T., & Hajjar, E. R. (2014). Clinical consequences of polypharmacy in elderly. Expert Opinion on Drug Safety, 13(1), 1–11. doi: 10.1517/14740338.2013.827660
   Web of Science ®Google Scholar
• Malek, N., & Grosset, D. G. (2015). Medication adherence in patients with Parkinson's disease. CNS Drugs, 29(1), 47–53. doi: 10.1007/s40263-014-0220-0
   PubMed Web of Science ®Google Scholar
• Mate, K. E., Kerr, K. P., Pond, D., Williams, E. J., Marley, J., Disler, P.,… Magin, P. J. (2015). Impact of multiple low-level anticholinergic medications on anticholinergic load of community-dwelling elderly with and without dementia. Drugs & Aging, 32(2), 159–167. doi: 10.1007/s40266-014-0230-0
   Web of Science ®Google Scholar
• McCracken, R., McCormack, J., McGregor, M. J., Wong, S. T., & Garrison, S. (2017). Associations between polypharmacy and treatment intensity for hypertension and diabetes: A cross-sectional study of nursing home patients in British Columbia, Canada. BMJ Open, 7(8), 1–6. doi: 10.1136/bmjopen-2017-017430
   Web of Science ®Google Scholar
• McCullagh, C. D., Craig, D., McIlroy, S. P., & Passmore, A. P. (2001). Risk factors for dementia. Advances in Psychiatric Treatment, 7(1), 24–31. doi: 10.1192/apt.7.1.24
   Google Scholar
• Molto, A., & Dougados, M. (2014). Comorbidity indices. Clinical and Experimental Rheumatology, 32(5 Suppl 85), S–131–134.
   Web of Science ®Google Scholar
• Monastero, R., Palmer, K., Qiu, C., Winblad, B., & Fratiglioni, L. (2007). Heterogeneity in risk factors for cognitive impairment, no dementia: Population-based longitudinal study from the Kungsholmen Project. American Journal of Geriatric Psychiatry, 15(1), 60–69. doi: 10.1097/01.jgp.0000229667.98607.34
   Web of Science ®Google Scholar
• Morrone, F. B., Schroeter, G., Petitembert, A. P., Faggiani, F. T., & De Carli, G. A. (2009). Potential interactions of central nervous system drugs used in the elderly population. Brazilian Journal of Pharmaceutical Sciences, 45, 227–234.
   Web of Science ®Google Scholar
• Murray, M. D., & Kroenke, K. (2001). Polypharmacy and medication adherence: Small steps on a long road. Journal of General Internal Medicine, 16(2), 137–139. doi: 10.1111/j.1525-1497.2001.01229.x
   Web of Science ®Google Scholar
• Onda, M., Imai, H., Takada, Y., Fujii, S., Shono, T., & Nanaumi, Y. (2015). Identification and prevalence of adverse drug events caused by potentially inappropriate medication in homebound elderly patients: A retrospective study using a nationwide survey in Japan. BMJ Open, 5 (8), e007581. doi: 10.1136/bmjopen-2015-007581
   PubMed Web of Science ®Google Scholar
• Orkaby, A. R., Cho, K., Cormack, J., Gagnon, D. R., & Driver, J. A. (2017). Metformin vs sulfonylurea use and risk of dementia in US veterans aged >/ = 65 years with diabetes. Neurology, 89(18), 1877–1885. doi: 10.1212/wnl.0000000000004586
   PubMed Web of Science ®Google Scholar
• Ostrom, J. R., Hammarlund, E. R., Christensen, D. B., Plein, J. B., & Kethley, A. J. (1985). Medication usage in an elderly population. Medical Care, 23 (2), 157–164.
   Web of Science ®Google Scholar
• Park, H.-Y., Park, J.-W., Song, H. J., Sohn, H. S., & Kwon, J.-W. (2017). The association between polypharmacy and dementia: A nested case-control study based on a 12-Year longitudinal cohort database in South Korea. Plos One, 12(1), e0169463. doi: 10.1371/journal.pone.0169463
   PubMed Web of Science ®Google Scholar
• Parsons, C. (2017). Polypharmacy and inappropriate medication use in patients with dementia: An underresearched problem. Therapeutic Advances in Drug Safety, 8(1), 31–46. doi: 10.1177/2042098616670798
   PubMed Web of Science ®Google Scholar
• Poblador-Plou, B., Calderon-Larranaga, A., Marta-Moreno, J., Hancco-Saa- vedra, J., Sicras-Mainar, A., Soljak, M., & Prados-Torres, A. (2014). Comorbidity of dementia: A cross-sectional study of primary care older patients. BMC Psychiatry [Electronic Resource], 14, 84–84. doi: 10.1186/1471-244X-14-84
   PubMed Web of Science ®Google Scholar
• Rattagan, M. L., Lisei, D., Rojas, G. J., Persi, G. G., Parisi, V. L., Lopez Vicchi, M., … Gatto, E. M. (2016). [Rational use of psychotropic medications and sedative load in older adults with and without dementia]. Vertex (Buenos Aires, Argentina), XXVII(129), 332–338.
   PubMedGoogle Scholar
• Riccio, D., Solinas, A., Astara, G., & Mantovani, G. (2007). Comprehensive geriatric assessment in female elderly patients with Alzheimer disease and other types of dementia. Archives of Gerontology and Geriatrics, 44 (Suppl 1), 343–353. doi: 10.1016/j.archger.2007.01.047
   Google Scholar
• Rizzi, L., Rosset, I., & Roriz-Cruz, M. (2014). Global epidemiology of dementia: Alzheimer's and vascular types. BioMed Research International, 2014, 8. doi: 10.1155/2014/908915
   Google Scholar
• Rocca, W. A., Mielke, M. M., Vemuri, P., & Miller, V. M. (2014). Sex and gender differences in the causes of dementia: A narrative review. Maturi- tas, 79(2), 196–201. doi: 10.1016/j.maturitas.2014.05.008
   PubMed Web of Science ®Google Scholar
• Sadowsky, C. H., & Galvin, J. E. (2012). Guidelines for the management of cognitive and behavioral problems in dementia. Journal of the American Board of Family Medicine, 25(3), 350–366. doi: 10.3122/jabfm.2012.03.100183
   Web of Science ®Google Scholar
• Sarkar, U., Lyles, C., Steinman, M., Huang, E. S., Moffet, H. H., Whitmer, R. A., … Karter, A. J. (2017). Changes in medication use after dementia diagnosis in an observational cohort of individuals with diabetes mellitus. Journal of the American Geriatrics Society, 65(1), 77–82. doi: 10.1111/jgs.14429
   PubMed Web of Science ®Google Scholar
• Schubert, C. C., Boustani, M., Callahan, C. M., Perkins, A. J., Carney, C. P., Fox, C., . Hendrie, H. C. (2006). Comorbidity profile of dementia patients in primary care: Are they sicker ? Journal of the American Geriatrics Society, 54(1), 104–109. doi: 10.1111/j.1532-5415.2005.00543.x
   Web of Science ®Google Scholar
• Sharifi, H., Hasanloei, M. A., & Mahmoudi, J. (2014). Polypharmacy-induced drug-drug interactions; threats to patient safety. Drug Research (Stuttg), 64(12), 633–637. doi: 10.1055/s-0033-1363965
   Google Scholar
• Sharp, E. S., & Gatz, M. (2011). Relationship between education and dementia: An updated systematic review. Alzheimer Disease and Associated Disorders, 25(4), 289–304. doi: 10.1097/WAD.0b013e318211c83c
   PubMed Web of Science ®Google Scholar
• Shumaker, S. A., Legault, C., Kuller, L., Rapp, S. R., Thal, L., Lane, D. S., … Coker, L. H. (2004). Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA, 291 (24), 2947–2958. doi: 10.1001/jama.291.24.2947
   Google Scholar
• Silay, K., Yalcin, A., Akinci, S., Gursoy, F. G., & Sener Dede, D. (2017). Charl- son Comorbidity Index, inappropriate medication use and cognitive impairment: Bermuda Triangle. Wiener Klinische Wochenschrift, 129 (21–22), 799–804. doi: 10.1007/s00508-017-1253-4
   PubMed Web of Science ®Google Scholar
• Stang, A. (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European Journal of Epidemiology, 25(9), 603–605. doi: 10.1007/s10654-010-9491-z
   PubMed Web of Science ®Google Scholar
• Starr, J. M., & Whalley, L. J. (1994). Drug-induced dementia. Incidence, management and prevention. Drug Safety, 11(5), 310–317.
   Web of Science ®Google Scholar
• Tjia, J., Rothman, M. R., Kiely, D. K., Shaffer, M. L., Holmes, H. M., Sachs, G. A., & Mitchell, S. L. (2010). Daily medication use in nursing home residents with advanced dementia. Journal of the American Geriatrics Society, 58(5), 880–888. doi: 10.1111/j.1532-5415.2010.02819.x
   Web of Science ®Google Scholar
• Trombim, L. B., Fermino, B. L., Kruger, A. J., Vaz, F. N. C., Nascimento, L., Silva, W. C. F. N. d.,… Bonini, J. S. (2016). Incidence of polypharmacy in Alzheimer's disease elderly patients from Guarapuava City (Parana, Brazil). African Journal of Pharmacy and Pharmacology, 10(17), 364369.
   Google Scholar
• van der Flier, W. M., & Scheltens, P. (2005). Epidemiology and risk factors of dementia. Journal of Neurology, Neurosurgery, and Psychiatry, 76 (Suppl 5), v2–v7. doi: 10.1136/jnnp.2005.082867
   PubMedGoogle Scholar
• Vetrano, D. L., Tosato, M., Colloca, G., Topinkova, E., Fialova, D., Gindin, J., … Onder, G. (2013). Polypharmacy in nursing home residents with severe cognitive impairment: Results from the SHELTER Study. Alzheimer's Dementia, 9(5), 587–593. doi: 10.1016/j.jalz.2012.09.009
   Web of Science ®Google Scholar
• Virot, P. (2017). 10 facts on dementia. Retrieved from http://origin.who.int/features/factfiles/dementia/en/
   Google Scholar
• Voukelatou, P., Vrettos, I., Bitsikokou, A., Rapti, E., Sfendouraki, E., Ragkou, A., … Kalliakmanis, A. (2016). Diseases linked to polypharmacy and consequences of multiple drug use in consecutively admitted elderly patients at the time of admission. European Geriatric Medicine, 7S1, S29–S259.
   Google Scholar
• Wawruch, M., Zikavska, M., Wsolova, L., Kuzelova, M., Tisonova, J., Gajdosik, J., . Kristova, V. (2008). Polypharmacy in elderly hospitalised patients in Slovakia. Pharmacy World & Science, 30(3), 235–242. doi: 10.1007/s11096-007-9166-3
   Google Scholar
• Weiner, D. K., Hanlon, J. T., & Studenski, S. A. (1998). Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly. Gerontology, 44(4), 217–221.
   Web of Science ®Google Scholar
• Weintraub, S., Mercaldo, N., Harris, A. T., & Lau, D. T. (2008). P2-281: Polypharmacy among community-dwelling elderly patients with dementia: Analysis of the National Alzheimer's Coordinating Center uniform data set. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 4(4), T454. doi: 10.1016/j.jalz.2008.05.1357
   Google Scholar
• Wells, G. A., Shea, B., O'Connell, D., Peterson, J., Welch, V., Losos, M., & Tug- well, P. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Retrieved from http://www. ohri.ca/programs/clinical_epidemiology/oxford.asp
   Google Scholar
• Wimo, A., Jonsson, L., Bond, J., Prince, M., & Winblad, B. (2013). The worldwide economic impact of dementia 2010. Alzheimer's Dementia, 9(1), 1–11.e13. doi: 10.1016/j.jalz.2012.11.006
   Web of Science ®Google Scholar
• Woolf, B. (1955). On estimating the relation between blood group and disease. Annals of Human Genetics, 19(4), 251–253.
   Web of Science ®Google Scholar
• Wu, Y. H., Lai, C. Y., & Chang, Y. S. (2015). Antipsychotic polypharmacy among elderly patients with schizophrenia and dementia during hospitalization at a Taiwanese psychiatric hospital. Psychogeriatrics, 15(1), 7–13. doi: 10.1111/psyg.12067
   PubMed Web of Science ®Google Scholar